Trial Profile
Ruxolitinib for Chuvash Polycythemia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Polycythaemia
- Focus Expanded access; Therapeutic Use
- 07 May 2018 Status changed from recruiting to completed.
- 30 Apr 2015 New trial record